ascopubs.org

Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-TKI in EGFR-mutated advanced/metastatic non-small cell lung cancer.

Onkoras-101: A phase 1a/1b open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of BBO-8520 in subjects with advanced KRASG12C mutant non-small-cell lung cancer. This ...
ascopubs.org

Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-TKI, in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung ...

SWOG S2302, PRAGMATICA-LUNG: A prospective randomized study of ramucirumab plus pembrolizumab (PR) versus standard of care (SOC) for participants previously treated with immunotherapy for stage IV or ...
Cancer Research

American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
IEEE

A Multifrequency Superposition Methodology to Achieve High Efficiency and Targeted Power Distribution for a Multiload MCR WPT System

Abstract: Magnetically coupled resonant (MCR) wireless power transfer (WPT) is one of the most promising WPT technologies for its remarkable capability of simultaneous noncontact power transfer for ...
Property Week

MCR splashes £123m on hotel and serviced apartments for new brand

The three serviced apartment blocks and a hotel in Kensington and Chelsea will help seed a new, £500m hospitality platform.